Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 3, 2019 - Issue 1
Journal homepage
112
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A case of anti-Mi-2 antibody-positive dermatomyositis associated with malignant lymphoma

Masafumi OhashiDepartment of Dermatology, Ogaki Municipal Hospital, Ogaki City, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-3604-3232
ORCID Icon,
Hajime TakagiDepartment of Dermatology, Ogaki Municipal Hospital, Ogaki City, Japan;
,
Masaya HayakawaDepartment of Hematology, Ogaki Municipal Hospital, Ogaki City, Japan;
,
Yasuhito HamaguchiDepartment of Molecular Pathology of Skin, Kanazawa University Graduate School of Medicine, Kanazawa City, Japan;
&
Mariko SeishimaDepartment of Dermatology, Gifu University Graduate School of Medicine, Gifu City, Japan
Pages 62-66 | Received 04 Jun 2018, Accepted 30 Jul 2018, Published online: 04 Sep 2018

References

  • Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a-population-based study. Lancet. 2001;357:96–100.
  • Marie I, Guillevin L, Menard J-F, et al. Hematological malignancy associated with polymyositis and dermatomyositis. Autoimmunity Rev. 2012;11:615–620.
  • Joerg-Patrick S. Inflammatory myopathies and lymphoma. J Neurol Sci. 2016;369:377–389.
  • Bohan A, Peter JB. Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med. 1975;292:403–407.
  • Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985;23:881–888.
  • Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70:360–374.
  • Satoh M, Tanaka S, Ceribelli A, et al. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clinic Rev Allerg Immunol. 2017;52:1–19.
  • Targoff IN, Mamyrova G, Trieu EP, et al. A novel autoantibody to a 155-kD protein is associated with dermatomyositis. Arthritis Rheum. 2006;54:3682–3689.
  • Fujimoto M, Hamaguchi Y, Kaji K, et al. Myositis-specific anti-155/140 autoantibodies target transcriptional intermediary factor 1 family proteins. Arthritis Rheum. 2012;64:513–522.
  • Chinoy H, Fertig N, Oddis CV, et al. The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis. 2007;66:1345–1349.
  • Fujimoto M, Murakami A, Kurei S, et al. Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis. J Dermatol Sci. 2016;84:272–281.
  • Hengstman GJD, Vree Egberts WTM, Seelig HP, et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis. 2006;65:242–245.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.